Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02071836 · ClinicalTrials.gov registry record · NA

A Web Application to Reduce Heavy Drinking in First-time DWI Offenders

A NA study of Heavy Drinking and Driving Under the Influence, sponsored by Behavior Therapy Associates.

Completed
Registry status
NA
Development phase
58
Enrollment target
1
Study location

NCT02071836: Completed NA study of Heavy Drinking and Driving Under the Influence, sponsored by Behavior Therapy Associates.

NCT02071836 is a NA study of Heavy Drinking and Driving Under the Influence that has completed, run by Behavior Therapy Associates. The registered enrollment target is 58 participants, below the 343-participant average among 9 other Heavy Drinking trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02071836, a NA study of Heavy Drinking and Driving Under the Influence, has completed, sponsored by Behavior Therapy Associates.

COMPLETED
Registry status
NA
Development phase
58 participants
Enrollment target
1
Study location

Study Summary

The overall objective of this project is to develop, evaluate, and disseminate a web application for first-time DWI offenders that will provide them with an age-appropriate brief motivational intervention (BMI) to motivate them to reduce their drinking and a cognitive behavioral intervention (CBI) for to help them achieve and maintain abstinence. The goal is to reduce heavy drinking and consequently the risk for future drunk driving. The specific objectives of this Phase II are: * Completing the development of the Right Turns prototype based on feedback from the Phase I pilot study participants. This includes: providing more structure and guidance as participants work in the Tool Box section of the program; simplifying the content of the Tool Box; further R\&D in the text messaging feature for 2nd and 3rd tier cellular providers; implement a customized pdf report function for progress reports from the program to users' probation officers (under control of the user); developing a follow-up component and outcome reports; and revising the videos in the Tool Box to reflect greater diversity and a younger population of drinkers. * Conducting a randomized clinical trial of the program with first time DWI/DUI offenders who are recruited locally, collecting follow-up data, analyzing the data, and reporting the results.

Primary Outcome

Quantity/frequency of drinking in previous 3 months

Interventions

  • BEHAVIORAL Treatment as usual
  • BEHAVIORAL Right Turns web application

Study Locations (1)

New Mexico

  • Behavior Therapy Associates, LLC - Albuquerque

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2014-05
Est. Completion 2016-08
Phase NA
Behavior Therapy Associates

3 total trials

What the finished NCT02071836 record still lists

NCT02071836 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 58 participants, a relatively small participant target, below the 343-participant average among 9 other Heavy Drinking trials with a reported enrollment target (83% lower).

The record links to 4 conditions, with Heavy Drinking appearing as the primary indexed condition, and to 2 interventions - of which Treatment as usual is the first listed.

NCT02071836 reports a single indexed study location in New Mexico.

Frequently Asked Questions

What is clinical trial NCT02071836 about?

NCT02071836 is a clinical study titled "A Web Application to Reduce Heavy Drinking in First-time DWI Offenders". The overall objective of this project is to develop, evaluate, and disseminate a web application for first-time DWI offenders that will provide them with an age-appropriate brief motivational intervention (BMI) to motivate them to reduce their drinking and a cognitive behavioral intervention (CBI) f...

What is the current status of trial NCT02071836?

This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2014-05. Estimated completion is 2016-08.

What conditions does trial NCT02071836 study?

This clinical trial studies the following conditions: Heavy Drinking, Driving Under the Influence, Alcohol Abstinence, Driving While Intoxicated.

What interventions are being tested in trial NCT02071836?

The interventions under investigation include: Treatment as usual (BEHAVIORAL), Right Turns web application (BEHAVIORAL).

Who is sponsoring clinical trial NCT02071836?

This trial is sponsored by Behavior Therapy Associates, which has 3 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02071836 being conducted?

This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heavy Drinking

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02071836's enrollment target sits among peer trials

58 9th of 9 higher than 1 of 9 other Heavy Drinking trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heavy Drinking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03587844 · 58 participants · Phase 2

    Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients

  • NCT03630991 · 58 participants · Phase 1

    Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy

  • NCT03949855 · 58 participants · Phase 2

    Belimumab With Rituximab for Primary Membranous Nephropathy

  • NCT04069273 · 58 participants · Phase 2

    Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02071836, the US trial registry maintained by the National Library of Medicine. NCT02071836 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.